The document provides compositions such as dietary supplements. Such compositions can be used to reduce pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis. The document also provides methods for reducing pain, inflammation, stiffness, and/or discomfort associated with inflammatory conditions such as arthritis.

A composition for food and a fat absorption inhibitor, each including a seaweed polyphenol and a tea extract.

A composition for food and a fat absorption inhibitor, each including a seaweed polyphenol and a tea extract.

Hormesis model (i.e. a toxicant excitation effect or a low dose promoting effect) is firstly used to study the relationship between the amount and efficacy of tea seed meal in feed industry. The amount of the tea seed meal as feed additive for the low dose promoting effect is determined to be 0.25-4 kg per ton of complete feed in the monogastric animal feed. The use method and the amount of the tea seed meal as feed additive can improve animal growth performance, such as increase daily weight gain, improve feed conversion ratio and decrease mortality.

Hormesis model (i.e. a toxicant excitation effect or a low dose promoting effect) is firstly used to study the relationship between the amount and efficacy of tea seed meal in feed industry. The amount of the tea seed meal as feed additive for the low dose promoting effect is determined to be 0.25-4 kg per ton of complete feed in the monogastric animal feed. The use method and the amount of the tea seed meal as feed additive can improve animal growth performance, such as increase daily weight gain, improve feed conversion ratio and decrease mortality.

The present specification discloses a composition for external application to skin, containing a tea plant root extract as an active ingredient, for treatment of skin damage caused by fine dust, whereby the expression level of one or more selected from a group consisting of IL-36G (NM_019618), S100A7 (NM_002963), S100A8 (NM_002964) and XDH (NM_000379), which are genes in skin cells the expression level of which is affected by fine dust, is regulated to a normal level.

The present specification discloses a composition for external application to skin, containing a tea plant root extract as an active ingredient, for treatment of skin damage caused by fine dust, whereby the expression level of one or more selected from a group consisting of IL-36G (NM_019618), S100A7 (NM_002963), S100A8 (NM_002964) and XDH (NM_000379), which are genes in skin cells the expression level of which is affected by fine dust, is regulated to a normal level.

A composition that includes at least one target supplement and at least one rehydration formulation is described. When the at least one target supplement is ingested as part of the composition, the bioavailability of at least one target supplement is enhanced as compared to when it is ingested separate from the composition. The at least one target supplement is absorbed more quickly and in a greater amount when it is ingested as part of the composition than when it is ingested separate from the composition. The composition also hydrates a subject more quickly.

A composition that includes at least one target supplement and at least one rehydration formulation is described. When the at least one target supplement is ingested as part of the composition, the bioavailability of at least one target supplement is enhanced as compared to when it is ingested separate from the composition. The at least one target supplement is absorbed more quickly and in a greater amount when it is ingested as part of the composition than when it is ingested separate from the composition. The composition also hydrates a subject more quickly.

The present disclosure relates to a composition for ameliorating a circulatory system disease, which contains a green tea extract with modified ingredient content. According to the present disclosure, it is possible to effectively prevent, ameliorate and treat circulatory system diseases without side effects and, thereby, to greatly help patients with circulatory system diseases and contribute to the development of related industries.